Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns
Launched by QUEEN FABIOLA CHILDREN'S UNIVERSITY HOSPITAL · Feb 19, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a technique called delayed cord clamping for babies born moderately or late preterm, which means they are born between 32 and 36 weeks of pregnancy. Normally, when a baby is born, the umbilical cord is clamped and cut right away, but this study is testing whether waiting a little longer to do this can help the baby breathe better and bond with their mother. When babies are born too early, their lungs may still be filled with fluid, making it hard for them to breathe. This technique may help them adapt better after birth, potentially reducing the need for extra medical help.
To participate in this trial, pregnant women must be expecting a single baby and be in the specified gestational age range. Women with certain health issues or complications, such as severe anemia or fetal distress, will not be eligible. Those who join the study can expect to have their baby's breathing and overall health monitored closely after birth, while also being able to stay near their baby during this important time. This research aims to find ways to improve health outcomes for preterm infants and strengthen the bond between mother and child.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Pregnant women followed-up in Brugmann University Hospital will be eligible to participate if:
- • The delivery takes place between 32 0/7 and 36 6/7 weeks of gestation
- • They carry singletons
- Exclusion Criteria:
- • Fetal anomalies including congenital malformations, anemia, and growth restriction with abnormal Dopplers.
- • Abnormal placentation such as placenta previa.
- • Signs of fetal distress necessitating an emergency cesarean section.
- • Maternal health issue including severe anemia (defined as hemoglobin level \< 7 g/dL), preeclampsia, and bleeding disorders.
- • Maternal refusal of the use of blood products.
- • General anesthesia for cesarian section.
- • Planned cord blood banking.
- • Total language barrier without possibility of translation
About Queen Fabiola Children's University Hospital
Queen Fabiola Children's University Hospital is a premier pediatric institution dedicated to advancing child health through innovative clinical research and compassionate care. As a leading sponsor of clinical trials, the hospital focuses on developing and evaluating new treatments and therapies for various pediatric conditions. With a multidisciplinary team of experienced clinicians and researchers, the institution fosters a collaborative environment that emphasizes patient safety, ethical standards, and the integration of cutting-edge scientific advancements. Through its commitment to enhancing pediatric healthcare, Queen Fabiola Children's University Hospital aims to improve outcomes for children and adolescents on a global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, , Belgium
Brussels, , Belgium
Patients applied
Trial Officials
Anna AMORUSO
Principal Investigator
HUDERF
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported